Mega Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	415.59	490.26	518.29	399.83	239.1
Short-Term Investments	-	2.9	7.98	8.7	223.53
Trading Asset Securities	20.11	-	-	-	-
Cash & Short-Term Investments	435.7	493.16	526.27	408.53	462.63
Cash Growth	-11.65%	-6.29%	28.82%	-11.69%	115.93%
Accounts Receivable	223.32	90.06	115.88	184.82	203.63
Other Receivables	1.29	-	-	5.53	0.04
Receivables	224.6	90.06	115.88	190.36	203.67
Inventory	39.5	4.61	4.41	3.51	3.28
Prepaid Expenses	-	17.14	1.84	-	-
Other Current Assets	27.66	20.63	19.38	16.69	15.78
Total Current Assets	727.46	625.59	667.78	619.08	685.36
Property, Plant & Equipment	67.63	79.26	94.05	46.91	51.13
Long-Term Investments	30.9	30.8	29.6	30.03	30.2
Other Intangible Assets	0.61	0.77	0.92	0.83	0.81
Long-Term Deferred Tax Assets	3.61	2.06	4.2	5.97	2.81
Other Long-Term Assets	2.19	-	-	2.88	1.88
Total Assets	832.4	738.48	796.54	705.7	772.18
Accounts Payable	137.76	28.8	39.69	34.76	29.2
Accrued Expenses	-	7.55	6.58	7.95	15.68
Current Portion of Long-Term Debt	2.08	2	1.91	-	-
Current Portion of Leases	6.02	-	5.99	6.48	6.22
Current Income Taxes Payable	0.12	1.72	0.6	0.12	6.53
Current Unearned Revenue	41.36	49.22	52.87	10.46	10.7
Other Current Liabilities	12.7	1.35	2.06	21.48	1.47
Total Current Liabilities	200.04	90.64	109.71	81.25	69.79
Long-Term Debt	16.65	18.73	20.72	-	-
Long-Term Leases	4.63	13.68	19.94	4.51	5.35
Long-Term Unearned Revenue	0.15	0.75	1.35	1.95	2.55
Total Liabilities	221.46	123.8	151.72	87.7	77.69
Common Stock	0.14	0.15	0.15	0.16	0.13
Additional Paid-In Capital	-	334.37	385.57	394.49	228.69
Retained Earnings	-	6.38	6.38	101.63	119.24
Treasury Stock	-	-27.98	-1.57	-	-
Comprehensive Income & Other	610.79	301.77	254.3	121.72	346.44
Shareholders' Equity	610.94	614.68	644.83	618	694.5
Total Liabilities & Equity	832.4	738.48	796.54	705.7	772.18
Total Debt	29.37	34.4	48.56	10.99	11.57
Net Cash (Debt)	406.33	458.75	477.71	397.55	451.06
Net Cash Growth	-11.43%	-3.97%	20.16%	-11.86%	135.56%
Net Cash Per Share	2.06	2.21	2.26	1.93	3.54
Filing Date Shares Outstanding	190.47	228.13	237.77	239.23	200
Total Common Shares Outstanding	190.47	228.13	237.77	239.23	200
Working Capital	527.42	534.95	558.07	537.83	615.57
Book Value Per Share	3.21	2.69	2.71	2.58	3.47
Tangible Book Value	610.33	613.91	643.91	617.16	693.69
Tangible Book Value Per Share	3.20	2.69	2.71	2.58	3.47
Land	-	34.74	-	-	-
Machinery	-	73.04	72.71	69.91	68.6
Construction In Progress	-	-	34.74	-	-
Leasehold Improvements	-	12.95	12.51	11.33	8.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.